These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9196081)

  • 41. Work-related allergy and asthma in spice mill workers - The impact of processing dried spices on IgE reactivity patterns.
    van der Walt A; Lopata AL; Nieuwenhuizen NE; Jeebhay MF
    Int Arch Allergy Immunol; 2010; 152(3):271-8. PubMed ID: 20150745
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increases in allergen-specific IgE in BAL after segmental allergen challenge in atopic asthmatics.
    Wilson DR; Merrett TG; Varga EM; Smurthwaite L; Gould HJ; Kemp M; Hooper J; Till SJ; Durham SR
    Am J Respir Crit Care Med; 2002 Jan; 165(1):22-6. PubMed ID: 11779725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Allergic bronchial asthma due to Dermatophagoides pteronyssinus hypersensitivity can be efficiently treated by inoculation of allergen-antibody complexes.
    Machiels JJ; Somville MA; Lebrun PM; Lebecque SJ; Jacquemin MG; Saint-Remy JM
    J Clin Invest; 1990 Apr; 85(4):1024-35. PubMed ID: 2318962
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bronchial provocation tests in etiologic diagnosis and analysis of asthma.
    Pepys J; Hutchcroft BJ
    Am Rev Respir Dis; 1975 Dec; 112(6):829-59. PubMed ID: 173214
    [No Abstract]   [Full Text] [Related]  

  • 45. Allergen-specific IgE is not detectable in the bronchial mucosa of nonatopic asthmatic patients.
    Pillai P; Fang C; Chan YC; Shamji MH; Harper C; Wu SY; Ohm-Laursen L; Durham SR; Menzies-Gow A; Rajakulasingam RK; Ying S; Corrigan CJ; Gould HJ
    J Allergy Clin Immunol; 2014 Jun; 133(6):1770-2.e11. PubMed ID: 24794682
    [No Abstract]   [Full Text] [Related]  

  • 46. Anti-IgE antibody may help treat some asthma patients.
    Hughes AT
    JAMA; 2000 Dec; 284(22):2859-60. PubMed ID: 11147975
    [No Abstract]   [Full Text] [Related]  

  • 47. [Anti-IgE therapy].
    Chazan R
    Pneumonol Alergol Pol; 2002; 70 Suppl 1():76-81. PubMed ID: 12518645
    [No Abstract]   [Full Text] [Related]  

  • 48. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma.
    Djukanović R; Wilson SJ; Kraft M; Jarjour NN; Steel M; Chung KF; Bao W; Fowler-Taylor A; Matthews J; Busse WW; Holgate ST; Fahy JV
    Am J Respir Crit Care Med; 2004 Sep; 170(6):583-93. PubMed ID: 15172898
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Obstruction of the small airways in the spirometric diagnosis of occupational bronchial asthma.
    Obtulowicz K; Laczkowska T; Kolarzyk E; Hudzik A
    J Investig Allergol Clin Immunol; 1998; 8(5):300-3. PubMed ID: 9827427
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Mechanisms of allergic asthma].
    Tonnel AB; Wallaert B; Prin L; Ramon P; Bart F
    Rev Mal Respir; 1986; 3(1):5-12. PubMed ID: 3520721
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [IgE regulation in asthma pathogenesis and development of a monoclonal anti-IgE antibody for the treatment of allergic asthma].
    Wang G; Wang ZL
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Jul; 26(7):427-30. PubMed ID: 14649229
    [No Abstract]   [Full Text] [Related]  

  • 52. Omalizumab in persistent severe bakers' asthma.
    Olivieri M; Biscardo CA; Turri S; Perbellini L
    Allergy; 2008 Jun; 63(6):790-1. PubMed ID: 18445199
    [No Abstract]   [Full Text] [Related]  

  • 53. Omalizumab in idiopathic anaphylaxis.
    Warrier P; Casale TB
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):257-8. PubMed ID: 19354075
    [No Abstract]   [Full Text] [Related]  

  • 54. [Bronchial asthma related to the mechanism of allergy--2) Immediate asthmatic response and late asthmatic response].
    Watanabe A; Mano K
    Nihon Rinsho; 1987 Aug; 45(8):1747-53. PubMed ID: 3682209
    [No Abstract]   [Full Text] [Related]  

  • 55. Specific bronchial hyperreactivity in patients with asthma in anamnesis and elevated serum levels of total IgE and/or of allergen-specific IgE.
    Malinowski R; Kruszewski J; Maleszka P
    Pneumonol Alergol Pol; 1992; 60 Suppl 1():37-40. PubMed ID: 1292843
    [No Abstract]   [Full Text] [Related]  

  • 56. [Immunotherapy of allergic diseases: present and future].
    Müller U
    Schweiz Med Wochenschr; 1983 Dec; 113(52):1982-8. PubMed ID: 6229874
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Late-phase IgE-mediated reactions.
    Lemanske RF; Kaliner M
    J Clin Immunol; 1988 Jan; 8(1):1-13. PubMed ID: 3284895
    [No Abstract]   [Full Text] [Related]  

  • 58. Omalizumab and changes in airway hyperresponsiveness.
    Currie GP; Saha S; Lee DK
    Am J Respir Crit Care Med; 2005 Jan; 171(1):88-9; author reply 89. PubMed ID: 15615890
    [No Abstract]   [Full Text] [Related]  

  • 59. Anti-IgE autoantibody in patients with bronchial asthma.
    Nawata Y; Koike T; Yanagisawa T; Iwamoto I; Itaya T; Yoshida S; Tomioka H
    Clin Exp Immunol; 1984 Nov; 58(2):348-56. PubMed ID: 6388923
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunotherapy of atopic disorders. Present state of the art and future perspectives.
    Zeiger RS; Schatz M
    Med Clin North Am; 1981 Sep; 65(5):987-1012. PubMed ID: 6457225
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.